Bioplasma

Manufacturer: Hyland's Inc. | Merical, Inc.
Effective date: 2022-11-30
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: legacy-cache
Hydrated at: 2026-08-01 21:45:52

Label at a glance#

ProductBioplasma

Active ingredientCALCIUM SULFATE ANHYDROUS, FERROSOFERRIC PHOSPHATE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM SULFATE, SILICON DIOXIDE, CALCIUM FLUORIDE, TRIBASIC CALCIUM PHOSPHATE

Label structure7 sections

Dosage and administration

Adults & Children ages 7 - 12 years: 4 tablets. Children ages 2 - 6 years: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes Manufactured for: for up to 8 doses) with acute conditions.

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

For relief of symptoms of colds, simple nervous tension, fatigue and headaches.

OTC - PURPOSE SECTION

For relief of symptoms of colds, simple nervous tension, fatigue and headaches

OTC - ACTIVE INGREDIENT SECTION

Calc Fluor 6X HPUS, Calc Phos 3X HPUS, Calc Sulph 3X HPUS, Ferrum Phos 3X HPUS, Kali Mur 3X HPUS, Kali Phos 3X HPUS, Kali Sulph 3X HPUS, Mag Phos 3X HPUS, Nat Mur 6X HPUS, Nat Phos 3X HPUS, Nat Sulphuricum 3X HPUS, Silicea 6X HPUS

“HPUS” indicates that the active ingredients are in the official Homeopathic Pharmacopœia of the United States.

Directions

DOSAGE & ADMINISTRATION SECTION

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if imprinted cap band is broken or missing.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product.

OTC - ASK DOCTOR SECTION

If symptoms persist for more than seven days or worsen, contact a licensed health care provider.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep all medications out of the reach of children.

INACTIVE INGREDIENT SECTION

Acacia Gum, Lactose N.F.

PRINCIPAL DISPLAY PANEL - 1000 TABLET BOTTLE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 54973-1068-2

HOMEOPATHIC

SINCE 1903

Hyland's^®

Bioplasma ^®

A combination of all

Twelve Cell Salts

For relief of symptoms of colds, simple

nervous tension,fatigue

and headaches*

1000 TABLETS

label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
54973-1068-1	2022-10-20	C162847	48780-1	e4f33bdf-a998-d8a0-e053-dadaa90a6e4e	Bioplasma
54973-1068-2	2022-10-20	C162847	48780-1	e4f33bdf-a998-d8a0-e053-dadaa90a6e4e	Bioplasma
54973-1068-6	2022-10-20	C162847	48780-1	e4f33bdf-a998-d8a0-e053-dadaa90a6e4e	Bioplasma
54973-1068-1	2022-07-29	C162847	48780-1	e4f33bdf-a998-d8a0-e053-dadaa90a6e4e	Bioplasma
54973-1068-2	2022-07-29	C162847	48780-1	e4f33bdf-a998-d8a0-e053-dadaa90a6e4e	Bioplasma
54973-1068-6	2022-07-29	C162847	48780-1	e4f33bdf-a998-d8a0-e053-dadaa90a6e4e	Bioplasma

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CALCIUM FLUORIDE	ACTIVE INGREDIENT	O3B55K4YKI	1
CALCIUM SULFATE ANHYDROUS	ACTIVE INGREDIENT	E934B3V59H	1
FERROSOFERRIC PHOSPHATE	ACTIVE INGREDIENT	91GQH8I5F7	1
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	ACTIVE INGREDIENT	HF539G9L3Q	1
POTASSIUM CHLORIDE	ACTIVE INGREDIENT	660YQ98I10	1
POTASSIUM PHOSPHATE, DIBASIC	ACTIVE INGREDIENT	CI71S98N1Z	1
POTASSIUM SULFATE	ACTIVE INGREDIENT	1K573LC5TV	1
SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	1
SODIUM CHLORIDE	ACTIVE INGREDIENT	451W47IQ8X	1
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	ACTIVE INGREDIENT	70WT22SF4B	1
SODIUM SULFATE	ACTIVE INGREDIENT	0YPR65R21J	1
TRIBASIC CALCIUM PHOSPHATE	ACTIVE INGREDIENT	91D9GV0Z28	1
CALCIUM CATION	ACTIVE MOIETY	2M83C4R6ZB	1
CHLORIDE ION	ACTIVE MOIETY	Q32ZN48698	1
FERROSOFERRIC PHOSPHATE	ACTIVE MOIETY	91GQH8I5F7	1
FLUORIDE ION	ACTIVE MOIETY	Q80VPU408O	1
MAGNESIUM CATION	ACTIVE MOIETY	T6V3LHY838	1
PHOSPHATE ION	ACTIVE MOIETY	NK08V8K8HR	1
POTASSIUM CATION	ACTIVE MOIETY	295O53K152	1
SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	1
SODIUM SULFATE ANHYDROUS	ACTIVE MOIETY	36KCS0R750	1
SULFATE ION	ACTIVE MOIETY	7IS9N8KPMG	1
ACACIA	INACTIVE INGREDIENT	5C5403N26O	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

Bioplasma
calcium fluoride, tribasic calcium phosphate, calcium sulfate anhydrous, ferrosoferric phosphate, potassium chloride, potassium phosphate, dibasic, potassium sulfate, magnesium phosphate, dibasic trihydrate, sodium chloride, sodium phosphate, dibasic, heptahydrate, sodium sulfate, and silicon dioxide
CALCIUM SULFATE ANHYDROUS
CALCIUM CATION
FERROSOFERRIC PHOSPHATE
POTASSIUM CHLORIDE
POTASSIUM CATION
POTASSIUM PHOSPHATE, DIBASIC
PHOSPHATE ION
POTASSIUM SULFATE
SULFATE ION
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
MAGNESIUM CATION
SODIUM CHLORIDE
CHLORIDE ION
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
SODIUM SULFATE
SODIUM SULFATE ANHYDROUS
SILICON DIOXIDE
ACACIA
LACTOSE
CALCIUM FLUORIDE
FLUORIDE ION
TRIBASIC CALCIUM PHOSPHATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
54973-1068	54973-1068-6, 54973-1068-1, 54973-1068-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CALCIUM SULFATE ANHYDROUS	E934B3V59H	ACTIB
FERROSOFERRIC PHOSPHATE	91GQH8I5F7	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
POTASSIUM PHOSPHATE, DIBASIC	CI71S98N1Z	ACTIB
POTASSIUM SULFATE	1K573LC5TV	ACTIB
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	HF539G9L3Q	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	70WT22SF4B	ACTIB
SODIUM SULFATE	0YPR65R21J	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	ACTIB
ACACIA	5C5403N26O	IACT
LACTOSE	J2B2A4N98G	IACT
CALCIUM FLUORIDE	O3B55K4YKI	ACTIB
TRIBASIC CALCIUM PHOSPHATE	91D9GV0Z28	ACTIM

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 55 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
ACACIA	ACACIA	5C5403N26O	CAPSULE / ORAL		20 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET, COATED / ORAL	156 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET, CHEWABLE / ORAL		121 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	POWDER / ORAL	800 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET, EXTENDED RELEASE / ORAL	34.4 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	POWDER, FOR SUSPENSION / ORAL		7386 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET / ORAL	70 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	SYRUP / ORAL	NA		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET, FILM COATED / ORAL	0.14 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET, ORALLY DISINTEGRATING / ORAL		7 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	SUSPENSION / ORAL		2 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET / BUCCAL	9.1 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	GUM, CHEWING / BUCCAL		280 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	LOZENGE / ORAL		108 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	CAPSULE, EXTENDED RELEASE / ORAL		64 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET / SUBLINGUAL	9.1 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET, DELAYED RELEASE / ORAL	30 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	SUSPENSION / INTRAMUSCULAR	1 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
2c40b4ed-2303-c696-e063-6394a90a4889			353c566e-a60e-48a1-8dad-965de29faa8d	2025-01-21	Warnings	Exact identifier spl set id: 353c566e-a60e-48a1-8dad-965de29faa8d